Medical management of advanced gastric cancer

被引：41

作者：

Hill, ME ^{[1
]}

Cunningham, D ^{[1
]}

机构：

[1] Royal Marsden NHS Trust, GI Unit, Sutton SM2 5PT, Surrey, England

来源：

CANCER TREATMENT REVIEWS | 1998年 / 24卷 / 02期

关键词：

D O I：

10.1016/S0305-7372(98)90077-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：113 / 118

页数：6

共 59 条

[41]

MOERTEL CG, 1976, CANCER, V38, P676

[42] CONTINUOUS 5-FLUOROURACIL INFUSION IN ADVANCED GASTRIC-CARCINOMA [J].

MOYNIHAN, T ;

HANSEN, R ;

ANDERSON, T ;

QUEBBEMAN, E ;

BEATTY, P ;

AUSMAN, R ;

RITCH, P ;

CHITAMBAR, C ;

VUKELICH, M .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (04) :461-464

[43]

MURAD AM, 1993, CANCER, V72, P37, DOI 10.1002/1097-0142(19930701)72:1<37::AID-CNCR2820720109>3.0.CO

[44]

2-P

[45] ETOPOSIDE (VP-16-213) - CURRENT STATUS OF AN ACTIVE ANTICANCER DRUG [J].

ODWYER, PJ ;

LEYLANDJONES, B ;

ALONSO, MT ;

MARSONI, S ;

WITTES, RE .

NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (11) :692-700

[46] INCREASING INCIDENCE OF ADENOCARCINOMA OF THE GASTRIC CARDIA AND ADJACENT SITES [J].

POWELL, J ;

MCCONKEY, CC .

BRITISH JOURNAL OF CANCER, 1990, 62 (03) :440-443

[47] PHASE-II STUDY WITH THE COMBINATION ETOPOSIDE, DOXORUBICIN, AND CISPLATIN IN ADVANCED MEASURABLE GASTRIC-CANCER [J].

PREUSSER, P ;

WILKE, H ;

ACHTERRATH, W ;

FINK, U ;

LENAZ, L ;

HEINICKE, A ;

MEYER, J ;

MEYER, HJ ;

BUENTE, H .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (09) :1310-1317

[48] RANDOMIZED COMPARISON OF FLUOROURACIL, EPIDOXORUBICIN AND METHOTREXATE (FEMTX) PLUS SUPPORTIVE CARE WITH SUPPORTIVE CARE ALONE IN PATIENTS WITH NONRESECTABLE GASTRIC-CANCER [J].

PYRHONEN, S ;

KUITUNEN, T ;

NYANDOTO, P ;

KOURI, M .

BRITISH JOURNAL OF CANCER, 1995, 71 (03) :587-591

[49]

SCARFFE JH, 1985, CANCER TREAT REP, V69, P1275

[50]

SCHNITZLER G, 1986, CANCER TREAT REP, V70, P477

← 1 2 3 4 5 6 →